OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
IDOG55

Indogulf Cropsciences Ltd

Agricultural ChemicalsVerified

Indogulf Cropsciences Ltd maintains a debt-to-equity ratio of 0.69, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.61, suggesting it can cover short-term obligations but with limited buffer. Free cash flow is reported at INR 16.58 million, which is significantly lower than operating cash flow of INR 533.39 million, indicating that capital expenditures are consuming a large portion of cash generated from operations. Profitability metrics show a return on equity (ROE) of 5.59% and a return on assets (ROA) of 2.39%, both below the industry median for Agricultural Chemicals. This suggests that the company is underperforming in terms of capital efficiency and asset utilization compared to its peers. Gross profit of INR 497.46 million and operating income of INR 171.33 million indicate a relatively narrow margin structure, which may limit resilience in a volatile market. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond India. This lack of diversification increases exposure to regional economic and regulatory risks. The absence of international revenue streams may also limit growth potential in the long term. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. Capital expenditures are expected to remain a drag on free cash flow, with a negative value of INR 248.48 million reported in the latest period. The company's risk assessment highlights a key flag: net cash is negative after subtracting total debt, which could constrain its ability to invest in growth opportunities or withstand a downturn. Recent filings and transcripts do not indicate any major strategic shifts or capital-raising activities. The company appears to be operating within a stable but low-growth environment, with no significant new product launches or market expansions disclosed in the latest financial reports.

30-day price · IDOG+11.45 (+21.1%)
Low$49.46High$73.50Close$65.59As of12 May, 00:00 UTC
Profile
CompanyIndogulf Cropsciences Ltd
TickerIDOG.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Indogulf Cropsciences Ltd is an agricultural chemicals company that produces and distributes crop protection products, primarily in the Indian market.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with a confidence level of 0.92.

Indogulf Cropsciences Ltd maintains a debt-to-equity ratio of 0.69, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.61, suggesting it can cover short-term obligations but with limited buffer. Free cash flow is reported at INR 16.58 million, which is significantly lower than operating cash flow of INR 533.39 million, indicating that capital expenditures are consuming a large portion of cash generated from operations. Profitability metrics show a return on equity (ROE) of 5.59% and a return on assets (ROA) of 2.39%, both below the industry median for Agricultural Chemicals. This suggests that the company is underperforming in terms of capital efficiency and asset utilization compared to its peers. Gross profit of INR 497.46 million and operating income of INR 171.33 million indicate a relatively narrow margin structure, which may limit resilience in a volatile market. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification beyond India. This lack of diversification increases exposure to regional economic and regulatory risks. The absence of international revenue streams may also limit growth potential in the long term. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. Capital expenditures are expected to remain a drag on free cash flow, with a negative value of INR 248.48 million reported in the latest period. The company's risk assessment highlights a key flag: net cash is negative after subtracting total debt, which could constrain its ability to invest in growth opportunities or withstand a downturn. Recent filings and transcripts do not indicate any major strategic shifts or capital-raising activities. The company appears to be operating within a stable but low-growth environment, with no significant new product launches or market expansions disclosed in the latest financial reports.
Key takeaways
  • Indogulf Cropsciences Ltd has a moderate debt load and a current ratio of 1.61, indicating acceptable but not robust liquidity.
  • The company's ROE of 5.59% and ROA of 2.39% are below industry medians, suggesting underperformance in capital efficiency.
  • Revenue is concentrated in a single business segment and geographic market, increasing exposure to regional risks.
  • Free cash flow is constrained by high capital expenditures, limiting reinvestment or shareholder returns.
  • The company's liquidity position is flagged as medium, with net cash negative after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.39B
Gross profit$497.5M
Operating income$171.3M
Net income$129.4M
R&D
SG&A
D&A
SBC
Operating cash flow$533.4M
CapEx-$248.5M
Free cash flow$16.6M
Total assets$5.42B
Total liabilities$3.11B
Total equity$2.32B
Cash & equivalents$23.5M
Long-term debt$1.59B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3$4.87B$381.7M$263.6M$217.4M
FY-2$5.50B$420.8M$224.2M$118.6M
FY-1$5.52B$480.8M$282.3M$136.9M
FY0$5.90B$560.9M$314.7M-$1.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3$4.14B$1.81B$36.1M
FY-2$5.18B$2.03B$34.9M
FY-1$5.42B$2.32B$23.5M
FY0$6.88B$2.75B$92.2M
PeriodOCFCapExFCFSBC
FY-4
FY-3-$70.1M-$132.1M$217.4M
FY-2-$570.1M-$201.6M$118.6M
FY-1$533.4M-$248.5M$136.9M
FY0-$147.6M-$421.8M-$1.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$1.39B$171.3M$129.4M$16.6M
FQ-6$1.32B$35.0M$13.5M
FQ-5$2.33B$247.9M$166.7M
FQ-4-$55.9M
FQ-3$1.26B$177.4M$98.0M$27.3M
FQ-2$1.89B$74.9M$38.7M
FQ-1$2.48B$293.9M$206.8M
FQ0$1.16B$89.9M$38.6M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$5.42B$2.32B$23.5M
FQ-6
FQ-5
FQ-4$5.98B$2.65B$57.5M
FQ-3$6.88B$2.75B$92.2M
FQ-2
FQ-1$8.66B$4.40B$120.0M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$533.4M-$248.5M$16.6M
FQ-6
FQ-5-$237.7M-$211.5M
FQ-4-$188.0M-$316.5M-$55.9M
FQ-3-$147.6M-$421.8M$27.3M
FQ-2
FQ-1-$816.9M-$149.7M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.32B
Net cash-$1.57B
Current ratio1.6
Debt/Equity0.7
ROA2.4%
ROE5.6%
Cash conversion4.1%
CapEx/Revenue-17.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricIDOGActivity
Op margin12.3%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin9.3%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin35.8%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-17.9%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity69.0%37.1% medp25 10.3% · p75 82.0%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:21 UTC#2cace22a
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 04:40 UTCJob: b9e188ed